Magnolol confers neurotrophic effects against MPTP/p-induced Parkinson’s disease in mice via anti-inflammatory, anti-apoptotic mechanisms and PI3K/AKT/GSK3β/MAPK/mTOR signalling regulation
A more thorough examination of the brain-protective effect of magnolol on dopaminergic neurons when combined with chronic PD is offered, bringing up the possibility of using ML as a new preventive and therapeutic drug.